NRILX
Price
$14.17
Change
+$0.25 (+1.80%)
Updated
Apr 24 closing price
Net Assets
195.21M
VTMNX
Price
$16.83
Change
+$0.24 (+1.45%)
Updated
Apr 24 closing price
Net Assets
204.73B
Ad is loading...

NRILX vs VTMNX

Header iconNRILX vs VTMNX Comparison
Open Charts NRILX vs VTMNXBanner chart's image
Neuberger Berman International Sel R6
Price$14.17
Change+$0.25 (+1.80%)
VolumeN/A
Net Assets195.21M
Vanguard Developed Markets Index Instl
Price$16.83
Change+$0.24 (+1.45%)
VolumeN/A
Net Assets204.73B
NRILX vs VTMNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NRILX vs. VTMNX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRILX is a Buy and VTMNX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTMNX has more cash in the bank: 205B vs. NRILX (195M). VTMNX pays higher dividends than NRILX: VTMNX (3.07) vs NRILX (1.33). NRILX was incepted earlier than VTMNX: NRILX (8 years) vs VTMNX (24 years). NRILX (0.95) is less costly to investors than VTMNX (0.03). NRILX is a more actively managed with annual turnover of: 69.00 vs. VTMNX (3.00). NRILX has a lower initial minimum investment than VTMNX: NRILX (0) vs VTMNX (5000000). NRILX annual gain was more profitable for investors over the last year : 6.90 vs. VTMNX (6.32). VTMNX return over 5 years is better than : 52.26 vs. NRILX (34.85).
NRILXVTMNXNRILX / VTMNX
Total Expense Ratio0.700.032,333%
Annual Report Gross Expense Ratio0.950.033,167%
Fund Existence8 years24 years-
Gain YTD7.0778.00788%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets195M205B0%
Annual Yield % from dividends1.333.0743%
Returns for 1 year6.906.32109%
Returns for 3 years11.3214.7677%
Returns for 5 years34.8552.2667%
Returns for 10 yearsN/A29.62-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLN3.510.19
+5.72%
Silence Therapeutics Plc
XERS4.280.15
+3.63%
Xeris Biopharma Holdings
NHI75.32-0.22
-0.29%
National Health Investors
PKX45.90-0.42
-0.91%
POSCO Holdings
VERB4.41-0.13
-2.80%
Verb Technology Company Inc